
Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Author(s) -
Nancy U. Lin,
Lisa A. Carey,
Minetta C. Liu,
Jerry Younger,
Steven E. Come,
Matthew G. Ewend,
Gordon J. Harris,
Elizabeth Bullitt,
Annick D. Van den Abbeele,
John W. Henson,
Xiaochun Li,
Rebecca Gelman,
Harold J. Burstein,
Elizabeth Kasparian,
David G. Kirsch,
Ann Crawford,
Fred H. Hochberg,
Eric P. Winer
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7w8k-g207
Subject(s) - lapatinib , cancer , human epidermal growth factor receptor 2 , oncology , medicine , breast cancer , epidermal growth factor receptor , cancer research , trastuzumab